CSE:MBAI - Post Discussion
Post by
MarketMakerss on Jan 25, 2024 5:41pm
LIFE & Special Warrant Offering for Gross Proceeds of $2.8M
Demonstrating the significant scalability of its tech alongside the size of its addressable market, MedBright AI (MBAI.c MBAIF) recently announced that Rejuvenation, a prominent dermatology group and leader in advanced dermatological care, is expanding its use of MedMatrix to include marketing for cosmetic treatments and clinical trial recruitment and data analysis.
Rejuvenation's extensive network includes 8 clinics spread across 3 provinces with a highly skilled team comprising of 21 dermatologists, 5 Mohs surgeons, 2 plastic surgeons, and 13 general practitioners specializing in dermatology.
With a mcap of only $22M, MBAI has been able to expand to 14 clinics, including a Yale University-Affiliated Clinic, and is strongly positioned to fix the $200 billion healthcare problem of congested waiting rooms. Successfully solving even a small percentage of the addressable market could mean quick multiples if they continue to execute on this path.
Plus, thisnews comes shortly after MBAI achieved its near-term goal of reaching US$100M in total clinic revenue under contract with MedMatrix.
Focused on the intersection of healthcare and technology to match patient needs with enhanced revenue opportunities, MedBright AI (MBAI.c MBAIF) is the primary shareholder of and is targeting the healthcare waiting room problem with MedMatrix.
As detailed in this short introduction video, MedMatrix is an AI-powered data analytics platform and engine that analyzes crucial aspects of healthcare facilities and works alongside healthcare professionals to drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic: https://youtu.be/f3bcx2T_GzQ?si=9CXluAYD43PEDMM9 In better aligning physician resources with patient needs, MedMatrix evaluates numerous factors related to a patient's background, clinical interaction history and other factors to predict the resource needs for their upcoming visits and optimize provider schedules, without the need for a new platform or additional training.
Yesterday, MedBright AI (MBAI.c MBAIF) announced a LIFE & Special Warrant Offering for gross proceeds up to ~$2.8 million. The net proceeds will be allocated towards
Posted on Behalf of MedBright AI Investments Inc.
Be the first to comment on this post